PRGO

#2142
PERRIGO COMPANY PLC
11.4500 USD
+1.81%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
11.4000
11.5650
Intervallo Annuale
9.2250
22.0100
Variazione giornaliera
+1.81%
Variazione Mensile
+21.10%
Variazione di 6 mesi
-46.79%
Variazione Annuale
-46.79%
Chiusura Precedente
11.2460
Apertura
11.4900
Bid
Ask
Minimo
11.4000
High
11.5650
Volume
867
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 1.5761 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.35
Rapporto prezzo/fatturato
0.45
Dividendi per azione
1.16
Rendimento da dividendi %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Notizie